Gujarat Inject (Kerala) Limited

BSE:524238 Stock Report

Market Cap: ₹358.6m

Gujarat Inject (Kerala) Past Earnings Performance

Past criteria checks 4/6

Gujarat Inject (Kerala) has been growing earnings at an average annual rate of 73.8%, while the Trade Distributors industry saw earnings growing at 28.8% annually. Revenues have been growing at an average rate of 99.8% per year. Gujarat Inject (Kerala)'s return on equity is 8%, and it has net margins of 4.5%.

Key information

73.8%

Earnings growth rate

74.4%

EPS growth rate

Trade Distributors Industry Growth27.3%
Revenue growth rate99.8%
Return on equity8.0%
Net Margin4.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Gujarat Inject (Kerala) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:524238 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24173810
30 Jun 2487200
31 Mar 2458100
31 Dec 234100
30 Sep 233000
30 Jun 233100
31 Mar 232000
31 Dec 222100
30 Sep 221100
30 Jun 221000
31 Mar 220000
31 Dec 210-100
30 Sep 210-100
30 Jun 210-100
31 Mar 210-100
31 Dec 200000
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000
30 Sep 190000
30 Jun 190000
31 Mar 190000
31 Dec 180000
30 Sep 180000
30 Jun 180000
31 Mar 180000
31 Dec 172000
30 Sep 175000
30 Jun 1710000
31 Mar 1716000
31 Dec 1614000
31 Mar 160000
31 Dec 150000
31 Mar 150000

Quality Earnings: 524238 has high quality earnings.

Growing Profit Margin: 524238's current net profit margins (4.5%) are lower than last year (19.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 524238 has become profitable over the past 5 years, growing earnings by 73.8% per year.

Accelerating Growth: 524238's earnings growth over the past year (1496.7%) exceeds its 5-year average (73.8% per year).

Earnings vs Industry: 524238 earnings growth over the past year (1496.7%) exceeded the Trade Distributors industry 22.7%.


Return on Equity

High ROE: 524238's Return on Equity (8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gujarat Inject (Kerala) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution